Nepal’s age gradient in hypertension, diabetes and cholesterol is steep — and it starts early
National survey data from Nepal paint a familiar but still unsettling picture: non-communicable disease risk climbs with age, yet many of the behaviors and metabolic abnormalities that feed later cardiovascular disease are already present in younger adults. In the 2019 STEPS Survey, investigators analyzed data from 3,219 participants aged 15 to 69 years and mapped age-specific patterns of hypertension, diabetes, and hypercholesterolemia alongside common risk factors. The goal was practical rather than abstract — to identify where prevention can still bend the curve before disease becomes entrenched.
The cohort had a mean age of 35.3 ± 12.8 years, and 56% were female. Even at a population level, the distribution of risk factors was unevenly concentrated by age. Tobacco use reached 50% among adults aged 60 years and older, while alcohol consumption affected 31.5% in that oldest group. Alcohol use was also striking in the youngest adults, with 30.7% of those aged 15 to 29 years reporting consumption. Physical inactivity was present in 18.9% of the full sample, a reminder that cardiometabolic risk is not confined to older age brackets or to people already carrying a diagnosis.
One sentence captures the clinical problem: the risk profile is being assembled long before disease is diagnosed.
Midlife carries the heaviest metabolic load
Age-group comparisons showed a clear shift in burden toward middle age. Overweight peaked at 30.2% among adults aged 30 to 44 years, while stress was highest in that same age band at 80.1%. Obesity reached its maximum prevalence in the 45 to 59 age group, where 9.0% of participants met that criterion. These are not isolated findings. They fit a pattern in which weight gain, occupational or household strain, and lifestyle exposures accumulate together, creating a metabolic environment that pushes blood pressure, glucose regulation, and lipid levels in the same direction.
The data on disease prevalence reinforced that gradient. Men had more than twice the odds of hypertension compared with women, with an odds ratio of 2.04 and a 95% confidence interval of 1.62 to 2.55. Age exerted an even stronger effect: adults aged 60 years or older had nearly fivefold higher odds of hypertension than younger reference groups, with an odds ratio of 4.92 and a 95% confidence interval of 3.35 to 7.22. Vascular stiffening, endothelial dysfunction, and the cumulative impact of lifestyle and cardiometabolic exposures provide a biologically plausible explanation for that rise. As arteries lose compliance over time, blood pressure becomes harder to control, and the risk of downstream stroke, heart failure, and kidney injury rises with it.
The midlife signal was even more pronounced for glucose and lipid abnormalities. Diabetes had an odds ratio of 6.34 in the 45 to 59 age group, with a 95% confidence interval of 3.58 to 11.23, making this the age band with the greatest measured burden. Hypercholesterolemia also clustered in that same group, with an odds ratio of 2.66 and a 95% confidence interval of 1.77 to 3.98. Insulin resistance, central adiposity, and age-related lipid changes likely converge here, creating a period in which silent disease can advance for years before it becomes clinically obvious.
Younger adults still carry preventable risk
The most policy-relevant detail in this survey is not simply that older adults were sicker. It is that younger adults were not protected from the behaviors that drive later disease. Alcohol use in the 15 to 29 age group was already common, physical inactivity was present across the sample, and stress burden was highest in the 30 to 44 year group, precisely when many people are balancing work, family, and limited time for preventive care. These exposures matter because they seed future hypertension, dyslipidemia, and glucose intolerance long before a laboratory test crosses a diagnostic threshold.
The prevalence pattern supports age-specific prevention rather than a one-size-fits-all message. In youth and early adulthood, the emphasis has to be on behavior change, health literacy, and earlier screening for people who are already accumulating risk. In middle age, the priority shifts toward metabolic surveillance, early treatment of blood pressure and lipid abnormalities, and practical interventions that can reach people before complications develop. In older adults, continuity of care becomes central, because treatment interruption and poor follow-up can erase gains made earlier in the disease course.
A second sentence cuts through the rest: screening too late means the first diagnosis often follows the first complication.
Why the Nepal data matter for prevention policy
These findings come from nationally representative survey data, which gives them direct relevance for public health planning in Nepal. The study design allowed age-stratified comparisons across a broad adult age range, making it possible to see where risk concentrates rather than treating the population as a single undifferentiated group. That matters in countries where resources are limited and prevention programs must be targeted with precision. If younger adults are already drinking at substantial rates and showing meaningful levels of inactivity and stress, then a strategy focused only on older adults will miss the period when risk is most modifiable.
The survey also makes clear that the burden of hypertension, diabetes, and hypercholesterolemia rises in parallel with age, but not in isolation from social and behavioral context. Men and older adults carried the greatest hypertension risk, while middle-aged adults bore the heaviest metabolic burden. The practical consequence is straightforward: prevention cannot wait for clinic-based detection alone. Community screening, counseling on tobacco and alcohol, physical activity promotion, and routine measurement of blood pressure, glucose, and lipids need to be aligned with the age groups most likely to benefit.
This survey does not resolve every question about causal pathways, treatment access, or long-term outcomes, but it does define where the burden sits in contemporary Nepal. The next step is to translate age-stratified surveillance into age-stratified action, with screening and prevention beginning earlier than many health systems are currently designed to support.